Literature DB >> 15673350

Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations.

Chunliu Zhan1, Rosaly Correa-de-Araujo, Arlene S Bierman, Judy Sangl, Marlene R Miller, Stephen W Wickizer, Daniel Stryer.   

Abstract

OBJECTIVES: To assess the prevalence and correlates of potentially harmful drug-drug combinations and drug-disease combinations prescribed for elderly patients at outpatient settings.
DESIGN: Retrospective analysis of the 1995-2000 National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS).
SETTING: Physician offices and hospital outpatient departments. PARTICIPANTS: Outpatient visits by patients aged 65 and older in the NAMCS and NHAMCS (n=70,203). MEASUREMENTS: Incidences of six drug-drug combinations and 50 drug-disease combinations that can place elderly patients at risk for adverse events according to expert consensus panels.
RESULTS: Overall, 0.74% (95% confidence interval (CI)=0.65-0.83) of visits with two or more prescriptions had at least one inappropriate drug-drug combination, and 2.58% (95% CI=2.44-2.72) of visits with at least one prescription had one or more inappropriate drug-disease combinations. Of visits with a prescription of warfarin, 6.60% (95% CI=5.46-7.74) were prescribed a drug with potentially harmful interaction. Of patients with benign prostatic hypertrophy, 4.06% (95% CI=3.06-5.06) had at least one of six drugs that should be avoided. The number of drugs prescribed is most predictive of inappropriate drug-drug and drug-disease combinations.
CONCLUSION: Potentially harmful drug-drug and drug-disease combinations occur in various degrees in outpatient care in the elderly population. Targeting combinations such as those involving warfarin that are high in prevalence and potential harm offers a practical approach to improving prescribing and patient safety.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673350     DOI: 10.1111/j.1532-5415.2005.53112.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

1.  Exposure to potentially harmful drug-disease interactions in older community-dwelling veterans based on the Healthcare Effectiveness Data and Information Set quality measure: who is at risk?

Authors:  Mary Jo V Pugh; Catherine I Starner; Megan E Amuan; Dan R Berlowitz; Monica Horton; Zachary A Marcum; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2011-08-10       Impact factor: 5.562

2.  Identification of an updated set of prescribing--safety indicators for GPs.

Authors:  Rachel Spencer; Brian Bell; Anthony J Avery; Gill Gookey; Stephen M Campbell
Journal:  Br J Gen Pract       Date:  2014-04       Impact factor: 5.386

3.  [Heart failure patients in Primary Care: aging, comorbidities and polypharmacy].

Authors:  Gisela Galindo Ortego; Inés Cruz Esteve; Jordi Real Gatius; Leonardo Galván Santiago; Carmen Monsó Lacruz; Plácido Santafé Soler
Journal:  Aten Primaria       Date:  2010-12-22       Impact factor: 1.137

4.  Polypharmacy and older people--the GP perspective.

Authors:  M Vass; C Hendriksen
Journal:  Z Gerontol Geriatr       Date:  2005-09       Impact factor: 1.281

5.  Medication for older people--aspects of rational therapy from the general practitioner's point of view.

Authors:  M Vass; C Hendriksen
Journal:  Z Gerontol Geriatr       Date:  2005-06       Impact factor: 1.281

6.  Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults.

Authors:  Ilene H Zuckerman; Patricia Langenberg; Mona Baumgarten; Denise Orwig; Patricia J Byrns; Linda Simoni-Wastila; Jay Magaziner
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

Review 7.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

8.  Pharmacists' and pharmacy students' ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review).

Authors:  Sarah Snyder Lee; Ann K Schwemm; Jeffrey Reist; Matthew Cantrell; Michael Andreski; William R Doucette; Elizabeth A Chrischilles; Karen B Farris
Journal:  Am J Pharm Educ       Date:  2009-05-27       Impact factor: 2.047

9.  Trends in use of high-risk medications for older veterans: 2004 to 2006.

Authors:  Mary Jo V Pugh; Joseph T Hanlon; Chen-Pin Wang; Todd Semla; Muriel Burk; Megan E Amuan; Ashlei Lowery; Chester B Good; Dan R Berlowitz
Journal:  J Am Geriatr Soc       Date:  2011-08-30       Impact factor: 5.562

Review 10.  Introducing the Big Knowledge to Use (BK2U) challenge.

Authors:  Yehoshua Perl; James Geller; Michael Halper; Christopher Ochs; Ling Zheng; Joan Kapusnik-Uner
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.